Vertex Newswire

Comprehensive Real-Time News Feed for Vertex.

Results 1 - 20 of 245 in Vertex

  1. Patent Issued for Methods, Data Record, Software Interface, Data...Read the original story

    Wednesday Apr 16 | Hispanic Business

    ... application for transaction tax calculation and reporting. Examples of such an application are 'TaxWare', ' ', 'Vertex' and 'Datev'. "Moreover, U.S. Pat. No. 6,078,899 discloses a point of sale tax reporting and automatic collection system. U.S. ...

    Comment?

  2. Keeping it in the familyRead the original story w/Photo

    Wednesday Apr 16 | Beverley Today

    ... it easy to capture what they can do on paper, so I'm very passionate and excited about helping them." Robin launched Vertex as Sales Director at the beginning of March. Working with son Alex, the Business Manager, he plans to move into the managed ...

    Comment?

  3. Analysts View on Biotech Equities -- Research on Organovo Holdings,...Read the original story

    Tuesday Apr 15 | Sys-Con Media

    ... on the following equities: Organovo Holdings Inc. (NYSE MKT: ONVO), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI). Free technical research on ONVO, BMRN, VRTX ...

    Comment?

  4. Vertex Report Shows Increase in Sales Tax Rate Changes in 2013Read the original story

    Tuesday Apr 15 | Business Wire

    According to the yearly sales tax rate study issued today by Vertex Inc., the leading provider of sales tax solutions and services, the number of sales and use tax rate changes in the U.S. for year 2013 was 609, up significantly from 2012 when there were 463 changes.

    Comment?

  5. Investors shed tech, biotech stocksRead the original story w/Photo

    Saturday Apr 12 | Sunherald.com

    ... has slid 19 percent. Biotechnology companies have been hit just as hard. Gilead Sciences is down 16 percent and Vertex Pharmaceuticals has fallen 23 percent. Their sudden downfall comes as investors shift from riskier investments to safer areas like ...

    Comment?

  6. Why Biogen Idec Inc., Vertex Pharmaceuticals Incorporated, and...Read the original story

    Friday Apr 11 | The Motley Fool

    ... whether the recent slump in share prices was warranted or not, when Biogen reports its quarterly earnings. Shares of Vertex Pharmaceuticals also lagged the market, plunging 4% in trading today. Vertex's business is essentially reliant upon two ...

    Comment?

  7. Investors shed tech, biotech stocksRead the original story

    Friday Apr 11 | Monterey County Herald

    ... has slid 19 percent. Biotechnology companies have been hit just as hard. Gilead Sciences is down 16 percent and Vertex Pharmaceuticals has fallen 23 percent. Their sudden downfall comes as investors shift from riskier investments to safer areas like ...

    Comment?

  8. Cystic Fibrosis Therapeutics Market - Global Industry Analysis, Size, ...Read the original story

    Friday Apr 11 | SBWire

    ... basis of age, sex and mutation. Some of the major players operating in the market are Pari Pharma, AstraZeneca and Vertex Pharmaceuticals. This research report analyzes this market depending on its market segments, major geographies, and current ...

    Comment?

  9. Vertex to Announce First Quarter 2014 Financial Results on May 1Read the original story

    Thursday Apr 10 | Freshnews

    Vertex Pharmaceuticals Incorporated will report its first quarter 2014 financial results on Thursday, May 1, 2014 after the financial markets close.

    Comment?

  10. US stocks rally on Fed minutes, earnings newsRead the original story

    Wednesday Apr 9 | The Campbell Reporter

    ... percent, to 4,183.90. Facebook rose the most in the S&P 500, jumping 7.3 percent, followed closely by biotech company Vertex Pharmaceuticals, up 7 percent. Other names that saw renewed investor interest were biotech companies Boston Scientific, ...

    Comment?

  11. Stunning Spending Growth Prediction for Hepatitis CRead the original story w/Photo

    Thursday Apr 10 | The Motley Fool

    ... hepatitis C drugs have been among the most anticipated therapies. First, doctors, patients, and investors focused on Vertex Pharmaceuticals ' ( Doctors began delaying patient treatment with the previous standard of care, a side-effect laden ...

    Comment?

  12. Biotech Stocks Are Getting SmashedRead the original story

    Thursday Apr 10 | Silicon Alley Insider

    Among the big losers are Alexion Pharmaceuticals , Gilead Sciences , Biogen Idec , and Vertex Pharmaceuticals .

    Comment?

  13. Stocks rally on Fed, earnings newsRead the original story

    Thursday Apr 10 | San Mateo Daily Journal

    ... percent, to 4,183.90. Facebook rose the most in the S&P 500, jumping 7.3 percent, followed closely by biotech company Vertex Pharmaceuticals, up 7 percent. Other names that saw renewed investor interest were biotech companies Boston Scientific, ...

    Comment?

  14. U.S. stocks rally on Federal Reserve minutes, earnings newsRead the original story

    Thursday Apr 10 | Denver Post

    ... percent, to 4,183.90. Facebook rose the most in the S&P 500, jumping 7.3 percent, followed closely by biotech company Vertex Pharmaceuticals, up 7 percent. Other names that saw renewed investor interest were biotech companies Boston Scientific, ...

    Comment?

  15. Investors, buoyed by Fed report, go risky; indexes upRead the original story

    Wednesday Apr 9 | Times Herald-Record

    ... percent, to 4,183.90. Facebook rose the most in the S&P 500, jumping 7.3 percent, followed closely by biotech company Vertex Pharmaceuticals, up 7 percent. Other names that saw renewed investor interest were biotech companies Boston Scientific, ...

    Comment?

  16. stocks rally on Fed minutes, earnings newsRead the original story w/Photo

    Wednesday Apr 9 | News Times

    ... percent, to 4,183.90. Facebook rose the most in the S&P 500, jumping 7.3 percent, followed closely by biotech company Vertex Pharmaceuticals, up 7 percent. Other names that saw renewed investor interest were biotech companies Boston Scientific, ...

    Comment?

  17. Investors Shed Biotech StocksRead the original story

    Wednesday Apr 9 | Pharmaceutical Processing

    ... has slid 19 percent. Biotechnology companies have been hit just as hard. Gilead Sciences is down 16 percent and Vertex Pharmaceuticals has fallen 23 percent. Their sudden downfall comes as investors shift from riskier investments to safer areas like ...

    Comment?

  18. Will New Hepatitis C Guidelines From WHO Help Make Sovaldi And Other New Drugs More Affordable?Read the original story w/Photo

    Wednesday Apr 9 | Medical Daily

    ... of the U.S. cost. When compared to the $100,000 yearly cost reported by Forbes for Incivek, a protease inhibitor from Vertex Pharmaceuticals used for treating Hep C, Sovaldi is a bargain especially when examined from the perspective of total cure ...

    Comment?

  19. Tech stocks take tumbleRead the original story w/Photo

    Tuesday Apr 8 | NewsOK.com

    ... has slid 19 percent. Biotechnology companies have been hit just as hard. Gilead Sciences is down 16 percent and Vertex Pharmaceuticals has fallen 23 percent. Their sudden downfall comes as investors shift from riskier investments to safer areas like ...

    Comment?

  20. Associate Director / Director BiologyRead the original story

    Sunday Apr 6 | Nature Neuroscience

    Vertex Pharmaceuticals is a global biotech company committed to the discovery, development and commercialization of medicines for serious diseases with significant unmet medical needs.

    Comment?